HIV prevention tool is too slow to reach Africa, activists say.
Where this comes from
- Record sourced from PubMed, PMID 35737774.
- Also identified by DOI 10.1126/science.add6183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A long-lasting injectable drug was tested in seven African countries. But it's unclear when they'll have access to it.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Health Services Accessibility
- Pre-Exposure Prophylaxis